Showing results (381-390 of 1,794) with videos related to
Sort By:
Pageof 180
Mabs|July 6, 2023
Improved antibody pharmacokinetics by disruption of contiguous positive surface potential and charge reduction using alternate human frameworkRomain Ollier, Aline Fuchs, Florence Gauye, et al.Mabs|July 6, 2023
Therapeutic index improvement of antibody-drug conjugatesHans-Peter Gerber, Sanjeev Gangwar, Alison BettsMabs|August 23, 2023
Targeted chain-exchange-mediated reconstitution of a split type-I cytokine for conditional immunotherapyVedran Vasic, Can Buldun, Manfred Ritz, et al.Mabs|August 21, 2023
Selection of bispecific antibodies with optimal developability using FcRn‑Ph‑HPLC as an optimized FcRn affinity chromatography methodThomas Müller, Carolin Tasser, Michael Tesar, et al.Mabs|August 23, 2023
A machine learning strategy for the identification of key in silico descriptors and prediction models for IgG monoclonal antibody developability propertiesAndrew B Waight, David Prihoda, Rojan Shrestha, et al.Mabs|September 7, 2023
Biophysical characterization of PVR family interactions and therapeutic antibody recognition to TIGITSj J Diong, Aarti Jashnani, Andrew W Drake, et al.Mabs|June 29, 2023
Modifying antibody-FcRn interactions to increase the transport of antibodies through the blood-brain barrierJason Tien, Dmitri Leonoudakis, Ralitsa Petrova, et al.Mabs|June 8, 2023
Generation of a novel fully human non-superagonistic anti-CD28 antibody with efficient and safe T-cell co-stimulation propertiesAbdullah Elsayed, Christian Pellegrino, Louis Plüss, et al.Mabs|June 13, 2023
Characterization of anti-SARS-CoV-2 monoclonal antibodies focusing on antigen binding, neutralization, and FcγR activation via formation of immune complexMinoru Tada, Michihiko Aoyama, Akiko Ishii-WatabeMabs|September 28, 2023
A library approach for the de novo high-throughput isolation of humanized VHH domains with favorable developability properties following camelid immunizationPaul Arras, Han Byul Yoo, Lukas Pekar, et al.Pageof 180